Market capitalization
11.44 MUSD
—
—
−1.6409USD
−47.72 MUSD
27.51 MUSD
8.78 M
Beta (1Y)
2.99
About Telesis Bio, Inc.
Sector
Industry
CEO
Todd R. Nelson
Website
Headquarters
San Diego
Employees (FY)
147
Founded
2011
ISIN
US1920031010
FIGI
BBG011363VM3
Telesis Bio, Inc. engages in the provision of automated multi-omic and synthetic biology solutions. The firm also focuses on providing applications to enable researchers to rapidly, accurately, and reproducibly build or write synthetic DNA and mRNA and short oligonucleotides such as CRISPR guides that are ready to use in many downstream synthetic biology enabled markets. The company was founded by Daniel G. Gibson and J. Craig Venter on March 24, 2011 and is headquartered in San Diego, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
0.00
$TBIOTBIO story is over. Was a very tradeable stock! Hope you got some out of it too!
22
$TBIOAgain took some profitsThis stock is a gold mine. Very low public float, underfollowed, nice moves
Long
$TBIOMonster unleashed
$TBIOFollowing the pattern
$TBIOstuck
$TBIOLets go again?
Long
TBIO: Breakout Confirmed, 36.58% Potential Profit!Description: TBIO is trending higher and in an uptrend meaning that highs are getting higher and lows are getting higher. The uptrend line on the chart and the Trending Band Indicator (which measures trend) supports the Long Position.Stats:1. Ideal buy range: $21.5 - $23.22. Take profit: $30.02
Long
I believe that the dip we have recently seen in TBIO will provide for a good buying opportunity if it can hit the support levels that would minimize the risk of losses.Surely a bounce is awaiting, especially with all the complications that have recently arisen due to the covid vaccinations. Expe
$TBIOPullback buy possible
Long
55
TBIO Retesting the BreakoutI don't have a position here, but watching to see how it acts. I'd like to see some buying at the 10-day and at prior highs. The question is whether the breakout was a fakeout or if this is just a retest. We'll know soon enough.
Keep reading
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Stock brokers
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
TradeStation
Featured
Stocks, Futures
4.4Very Good
Learn more
Interactive Brokers
4.4Very Good
Learn more
Frequently Asked Questions
The current price of
TBIO
is
0.3310
USD
— it has decreased by
12.89
% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on
NASDAQ
exchange
Telesis Bio, Inc.
stocks are traded under the ticker
TBIO
.
Telesis Bio, Inc.
is going to release the next earnings report on
May 8, 2024
. Keep track of upcoming events with our Earnings Calendar.
TBIO
stock is
48.94
% volatile and has beta coefficient of
2.99
. Check out the list of the most volatile stocks — is
Telesis Bio, Inc.
there?
TBIO
earnings for the last quarter are
−0.37
USD
whereas the estimation was
−0.30
USD
which accounts for
−24.72
% surprise. Estimated earnings for the next quarter are
−0.24
USD
. See more details about
Telesis Bio, Inc. earnings.
for the last quarter amounts to
5.56 M
USD
despite the estimated figure of
7.40 M
USD
. In the next quarter revenue is expected to reach
7.00 M
USD
.
Yes, you can track
Telesis Bio, Inc. financialsin yearly and quarterly reports right on TradingView.
TBIO
stock has fallen by
23.02
% compared to the previous week, the month change is a
40.04
% fall, over the last year
Telesis Bio, Inc.
has showed a
88.59
% decrease.
TBIO
net income for the last quarter is
−17.69 M
USD
, while the quarter before that showed
−10.63 M
USD
of net income which accounts for
−66.37
% change. Track more
Telesis Bio, Inc. financial statsto get the full picture.
Today
Telesis Bio, Inc.
has the market capitalization of
11.44 M
, it has decreased by
1.78
% over the last week.
No,
TBIO
doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks,
TBIO
shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade
Telesis Bio, Inc.
stock right from TradingView charts — choose your broker and connect to your account.
TBIO
reached its all-time high on
Jun 30, 2021
with the price of
25.7000
USD
, and its all-time low was
0.3000
USD
and was reached on
Nov 21, 2023
.
See other stocks reaching their highest and lowest prices.
As of
Apr 19, 2024
, the company has
147.00
employees. See our rating of the largest employees — is
Telesis Bio, Inc.
on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So
Telesis Bio, Inc.
technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating
Telesis Bio, Inc.
stock shows the sell signal. See more of
Telesis Bio, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company.
Telesis Bio, Inc.
EBITDA is
−31.11 M
USD
, and current EBITDA margin is
−112.86
%. See more stats in
Telesis Bio, Inc. financial statements.
